John Overdeck Two Sigma Investments
John Overdeck is a co-founder of Two Sigma Investments, one of the world’s leading quantitative and technology-driven investment firms. Two Sigma applies data science, machine learning, and large-scale computing to markets across asset classes. Overdeck’s firm is a central reference point in discussions of modern systematic investing.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
ExxonMobil
XOM
|
+$161M |
| 2 |
Sherwin-Williams
SHW
|
+$149M |
| 3 |
Charter Communications
CHTR
|
+$148M |
| 4 |
Honeywell
HON
|
+$139M |
| 5 |
Boeing
BA
|
+$138M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$193M |
| 2 |
Altria Group
MO
|
+$169M |
| 3 |
Invesco QQQ Trust
QQQ
|
+$162M |
| 4 |
Walmart Inc
WMT
|
+$150M |
| 5 |
PayPal
PYPL
|
+$138M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 14.37% |
| 2 | Consumer Discretionary | 13.51% |
| 3 | Healthcare | 11.7% |
| 4 | Industrials | 10.07% |
| 5 | Financials | 6.83% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
CHL
3351
PUT
DELISTED
China Mobile Limited
CHL
| $232K | ﹤0.01% |
+5,500
| New | +$222K |
|
3352
Consolidated Water Co
CWCO
$479M
| $231K | ﹤0.01% |
14,196
-27,928
| -66% | -$461K |
|
|
LDL
3353
DELISTED
Lydall, Inc.
LDL
| $230K | ﹤0.01% |
11,200
-22,948
| -67% | -$475K |
|
3354
BlueLinx
BXC
$653M
| $229K | ﹤0.01% |
+16,100
| New | +$330K |
|
3355
Evertec
EVTC
$1.77B
| $228K | ﹤0.01% |
+6,700
| New | +$212K |
|
|
SRGA
3356
DELISTED
Surgalign Holdings, Inc. Common Stock
SRGA
| $228K | ﹤0.01% |
2,779
-872
| -24% | -$61.1K |
|
|
CBPX
3357
DELISTED
CONTINENTAL BUILDING PRODUCTS, INC.
CBPX
| $228K | ﹤0.01% |
+6,255
| New | +$206K |
|
3358
The Joint Corp
JYNT
$119M
| $227K | ﹤0.01% |
14,041
-85,584
| -86% | -$1.56M |
|
|
ARA
3359
DELISTED
American Renal Associates Holdings, Inc
ARA
| $227K | ﹤0.01% |
+21,888
| New | +$187K |
|
|
SAVE
3360
PUT
DELISTED
Spirit Airlines, Inc.
SAVE
| $226K | ﹤0.01% |
5,600
-38,000
| -87% | -$1.44M |
|
|
NBRV
3361
DELISTED
Nabriva Therapeutics plc Ordinary Shares Ireland
NBRV
| $226K | ﹤0.01% |
685
+279
| +69% | +$128K |
|
3362
Mitek Systems
MITK
$806M
| $225K | ﹤0.01% |
29,405
+1,844
| +7% | +$15.6K |
|
3363
PUT
Dave & Buster's
PLAY
$362M
| $225K | ﹤0.01% |
5,600
-400
| -7% | -$16K |
|
3364
PUT
Cleveland-Cliffs
CLF
$6.45B
| $224K | ﹤0.01% |
26,700
-117,800
| -82% | -$905K |
|
3365
PUT
Quest Diagnostics
DGX
$26.9B
| $224K | ﹤0.01% |
+2,100
| New | +$219K |
|
|
LL
3366
PUT
DELISTED
LL Flooring Holdings, Inc.
LL
| $224K | ﹤0.01% |
+22,900
| New | +$214K |
|
3367
CALL
Ally Financial
ALLY
$12.9B
| $223K | ﹤0.01% |
+7,300
| New | +$228K |
|
3368
Clarus
CLAR
$146M
| $222K | ﹤0.01% |
16,426
+4,388
| +36% | +$54.1K |
|
3369
Twin Disc
TWIN
$326M
| $222K | ﹤0.01% |
+20,166
| New | +$211K |
|
3370
CALL
Assured Guaranty
AGO
$3.26B
| $221K | ﹤0.01% |
+4,500
| New | +$215K |
|
3371
Stagwell
STGW
$2.17B
| $221K | ﹤0.01% |
79,486
-82,669
| -51% | -$223K |
|
3372
PUT
United Therapeutics
UTHR
$22B
| $220K | ﹤0.01% |
+2,500
| New | +$220K |
|
3373
PUT
Zillow
ZG
$8.53B
| $220K | ﹤0.01% |
4,800
-27,900
| -85% | -$1.03M |
|
|
PBBI
3374
DELISTED
PB Bancorp, Inc. Common Stock
PBBI
| $220K | ﹤0.01% |
+14,500
| New | +$207K |
|
|
SEE
3375
CALL
DELISTED
Sealed Air
SEE
| $219K | ﹤0.01% |
5,500
+500
| +10% | +$19.8K |
|
Similar funds
John Overdeck's Q4 2019 Portfolio in Review
As of Q4 2019, John Overdeck held 4,208 positions worth $33.2B, up 12% from $29.7B the previous quarter. Its ten largest holdings account for 7.6% of the portfolio.
John Overdeck deployed $1.15B of net new capital in Q4 2019, opening 818 new positions and adding to 1,341 existing holdings. Its largest new stake was Sherwin-Williams: 780,252 shares worth $152M.
By sector, the portfolio is most concentrated in Technology at 14% of assets, up from 14% a quarter earlier, followed by Consumer Discretionary and Healthcare.
On the sell side, the largest reduction was State Street SPDR S&P 500 ETF Trust, an estimated $193M trimmed.
- John Overdeck's largest Q4 2019 buy was Sherwin-Williams: 780,252 shares worth $152M.
- John Overdeck added most to ExxonMobil in Q4 2019, an estimated $161M increase.
- John Overdeck's biggest Q4 2019 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $193M.
- John Overdeck fully exited Walmart Inc in Q4 2019, selling an estimated $150M.
- John Overdeck's ten largest holdings make up 7.6% of its $33.2B portfolio in Q4 2019.
- John Overdeck opened 818 new positions and closed 612 in Q4 2019.
- John Overdeck's portfolio value rose 12% quarter-over-quarter to $33.2B.
Based on Two Sigma Investments's 13F filing for Q4 2019, filed 14 Feb 2020.